USFDA grants Mexiletine Orphan drug designation

USFDA grants Mexiletine Orphan drug designation

by admin- Monday, June 8th, 2020 04:19:58 PM

Pharma major Lupin introduced that the US Food and Drug Administration has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic issues.

News Updates